[go: up one dir, main page]

IL91814A - Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation - Google Patents

Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation

Info

Publication number
IL91814A
IL91814A IL9181489A IL9181489A IL91814A IL 91814 A IL91814 A IL 91814A IL 9181489 A IL9181489 A IL 9181489A IL 9181489 A IL9181489 A IL 9181489A IL 91814 A IL91814 A IL 91814A
Authority
IL
Israel
Prior art keywords
methyl
group
morpholino
pteridine
phenyl
Prior art date
Application number
IL9181489A
Other languages
English (en)
Other versions
IL91814A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL91814A0 publication Critical patent/IL91814A0/xx
Publication of IL91814A publication Critical patent/IL91814A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/06Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9181489A 1988-10-01 1989-09-28 Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation IL91814A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (de) 1988-10-01 1988-10-01 Verwendung von pteridinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
IL91814A0 IL91814A0 (en) 1990-06-10
IL91814A true IL91814A (en) 1994-02-27

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9181489A IL91814A (en) 1988-10-01 1989-09-28 Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation

Country Status (19)

Country Link
EP (1) EP0362645B1 (fr)
JP (1) JPH02256676A (fr)
KR (1) KR910006289A (fr)
AT (1) ATE106728T1 (fr)
AU (1) AU620645B2 (fr)
DD (1) DD299062A5 (fr)
DE (2) DE3833393A1 (fr)
DK (1) DK480489A (fr)
ES (1) ES2056174T3 (fr)
FI (1) FI92699C (fr)
HU (1) HU205761B (fr)
IL (1) IL91814A (fr)
MX (1) MX9203034A (fr)
NO (1) NO175979C (fr)
NZ (1) NZ230833A (fr)
PT (1) PT91836B (fr)
SU (1) SU1720491A3 (fr)
UA (1) UA8028A1 (fr)
ZA (1) ZA897414B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
AU770551B2 (en) * 1998-12-28 2004-02-26 4-Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
DE602004008304T2 (de) * 2003-09-12 2008-05-08 4 Aza Ip Nv Pteridin-derivate zur behandlung von erkrankungen im zusammenhang mit tnf-alpha
EP1673092B1 (fr) * 2003-10-17 2007-08-15 4 Aza Ip Nv Derives de pteridine substitues par des heterocycles et leur utilisation a des fins therapeutiques
RU2447074C2 (ru) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Птеридины, полезные в качестве ингибиторов hcv, и способы получения птеридинов
WO2008009078A2 (fr) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Dérivés de la quinazoline tri-substitués en 4,6-dl et en 2,4,6 utilisables pour traiter les infections virales
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
PL3321265T3 (pl) 2015-03-04 2020-11-16 Gilead Sciences, Inc. Związki 4,6-diamino-pirydo[3,2-d]pirymidynowe i ich wykorzystanie jako modulatorów receptorów toll-podobnych
KR20160003575A (ko) 2015-11-09 2016-01-11 정민시 발전기용 동력전달장치
EP3507288B1 (fr) 2016-09-02 2020-08-26 Gilead Sciences, Inc. Dérivés de 4,6-diamino-pyrido[3,2-d]pyrimidine en tant que modulateurs du recepteur de type toll
CA3035346A1 (fr) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Composes modulateurs du recepteur de type toll
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (fr) * 1966-10-14
DE1617336C2 (de) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1795515A1 (de) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Pteridinen
DE1795516A1 (de) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2-(2'-methylmorpholino)-7-morpholino-6-phenyl-pteridin
DE1921308A1 (de) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Herzwirksame Zubereitungen
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
FI894615A0 (fi) 1989-09-29
SU1720491A3 (ru) 1992-03-15
UA8028A1 (uk) 1995-12-26
ZA897414B (en) 1991-06-26
DK480489D0 (da) 1989-09-29
FI92699B (fi) 1994-09-15
PT91836A (pt) 1990-04-30
DD299062A5 (de) 1992-03-26
AU4174989A (en) 1990-04-05
ES2056174T3 (es) 1994-10-01
PT91836B (pt) 1995-07-18
HU205761B (en) 1992-06-29
ATE106728T1 (de) 1994-06-15
DE3833393A1 (de) 1990-04-05
IL91814A0 (en) 1990-06-10
FI92699C (fi) 1994-12-27
EP0362645A3 (fr) 1992-03-25
NO175979B (no) 1994-10-03
NO893879D0 (no) 1989-09-29
AU620645B2 (en) 1992-02-20
JPH02256676A (ja) 1990-10-17
HUT52504A (en) 1990-07-28
NZ230833A (en) 1991-05-28
FI894615A7 (fi) 1990-04-02
NO175979C (no) 1995-01-11
NO893879L (no) 1990-04-02
KR910006289A (ko) 1991-04-29
DE58907824D1 (de) 1994-07-14
EP0362645A2 (fr) 1990-04-11
DK480489A (da) 1990-04-02
MX9203034A (es) 1992-07-01
EP0362645B1 (fr) 1994-06-08

Similar Documents

Publication Publication Date Title
IL91814A (en) Pharmaceutical compositions comprising 6-phenyl (methyl)-2,7-bis (cyclic amino)-4- pteridinamines, certain novel such pteridines and their preparation
TWI896701B (zh) Wee1抑制劑之鹽及形式
CA2243994A1 (fr) Derives de 4-amino-pyrimidine, medicaments contenant ces composes, leur utilisation et leur procede de production
JP4456079B2 (ja) {6,7−ビス(2−メトキシ−エトキシ)−キナゾリン−4−イル}−(3e)の多形体
JP2022517396A (ja) Egfr阻害剤の塩、結晶形及びその製造方法
CN111217815B (zh) 含有喋啶酮骨架的化合物及其制备方法和应用
CN114502559B (zh) 二氢咪唑并嘧啶并嘧啶酮类化合物
NZ264133A (en) 2-[pyrrolidino, piperidino and hexamethyleneimino] substituted pyrimido pyrimidine derivatives and pharmaceutical compositions
CN102911118B (zh) 一类苯并氮杂卓类衍生物及其制备方法和用途
KR20120137403A (ko) 구연산아일데나필 결정 형태 o 및 그의 제조방법과 용도
US3301855A (en) Derivatives of 4-nu-(2-nu, nu-dimethylaminolower alkyl)-amino quinazoline
CN102079759B (zh) 6位取代的喹唑啉类衍生物、其制备方法和用途
CN107892691B (zh) 2,8,9-三取代-9h-嘌呤类化合物及其盐和应用
CN116715650A (zh) 尿石素类衍生物及其制备方法和应用
CN105001167B (zh) 1‑取代苯基‑3‑(4‑取代苯基氨基‑6‑喹唑啉基)脲类化合物及制备方法和用途
KR20190043842A (ko) 피리미딘-2-아민 유도체, 이의 제조방법 및 이를 포함하는 항암제
CN104119321B (zh) 二氢吲哚酮衍生物的二马来酸盐及其多晶型物
KR20220157398A (ko) Jak 억제제의 결정형 및 그의 적용
CN114394940B (zh) 一种环丙基-1,1二酰胺类化合物及其制备方法和应用
CN110483523B (zh) 一种吡唑并嘧啶衍生物表皮生长因子抑制剂及其制备方法与用途
CN114787162B (zh) 取代的咪唑并喹喔啉化合物及其应用
CN103265537B (zh) 抗肿瘤化合物、其制备方法和用途
CN103265535B (zh) 抗肿瘤化合物、其制备方法和用途
DE4225353A1 (de) Neue Pteridine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
CN118702697A (zh) 苯甲酰基吡咯并嘧啶类衍生物及其用途和制备方法

Legal Events

Date Code Title Description
RH Patent void